NCRI 2016

06–09 November 2016 | Liverpool, UK

At the 2016 NCRI Cancer Conference, the latest basic, translational and clinical cancer research was presented and discussed.

The program covered six main themes: diagnosis and therapy, epidemiology and prevention, healthcare delivery, information, patients and the public supportive, palliative care, survivorship, as well as cancer cell and model systems.

NCRI 2016

06–09 November 2016 | Liverpool, UK

At the 2016 NCRI Cancer Conference, the latest basic, translational and clinical cancer research was presented and discussed.

The program covered six main themes: diagnosis and therapy, epidemiology and prevention, healthcare delivery, information, patients and the public supportive, palliative care, survivorship, as well as cancer cell and model systems.

Functional imaging for influencing management: paradigm shift or pipe dream? 3:08
Functional imaging for influencing management: paradigm shift or pipe dream?
Nandita deSouza
The future of imaging – heading towards functional imaging 2:21
The future of imaging – heading towards functional imaging
Nandita deSouza • 6 Nov 2016
The use of molecular imaging to determine which patient should receive which targeted therapy 2:12
The use of molecular imaging to determine which patient should receive which targeted therapy
Arturo Chiti • 6 Nov 2016
Why the scientific community should be concerned with the accuracy of cancer coverage in the media 1:24
Why the scientific community should be concerned with the accuracy of cancer coverage in the media
Kat Arney • 6 Nov 2016
The challenges facing the development of molecular imaging modalities in targeted cancer therapy 2:21
The challenges facing the development of molecular imaging modalities in targeted cancer therapy
Arturo Chiti • 6 Nov 2016
How we talk about cancer to patients – what helthcare professionals should know 1:09
How we talk about cancer to patients – what helthcare professionals should know
Elena Semino • 6 Nov 2016
Occurence of APOBEC mutagenesis in human cancers 0:35
Occurence of APOBEC mutagenesis in human cancers
Reuben Harris • 6 Nov 2016
Group-based interventions for men with prostate cancer 4:23
Group-based interventions for men with prostate cancer
Penny Schofield • 6 Nov 2016
Challenges in SCLC research 0:59
Challenges in SCLC research
Corinne Faivre-Finn • 6 Nov 2016
The yeast cell cycle and what it has taught us 4:54
The yeast cell cycle and what it has taught us
Iain Hagan • 6 Nov 2016
Educating nurses about latest cancer treatments 1:52
Educating nurses about latest cancer treatments
Elaine Vickers • 6 Nov 2016
Overview of the National Cancer Research Institute (NCRI) Conference 2:19
Overview of the National Cancer Research Institute (NCRI) Conference
Karen Kennedy • 6 Nov 2016
The uses of molecular imaging for targeted cancer therapy 2:36
The uses of molecular imaging for targeted cancer therapy
Arturo Chiti • 6 Nov 2016
The implications of implementation studies on distress screening in cancer patients 1:25
The implications of implementation studies on distress screening in cancer patients
Alex Mitchell • 6 Nov 2016
Cancer cachexia and novel targeted therapies 2:17
Cancer cachexia and novel targeted therapies
David Currow • 6 Nov 2016
Fear of cancer recurrence – who is affected and how to address it? 3:43
Fear of cancer recurrence – who is affected and how to address it?
Gozde Ozakinci • 6 Nov 2016

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals